|Other Names||Calpain-11, 3422-, Calcium-activated neutral proteinase 11, CANP 11, CAPN11|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13870c was selected from the Center region of CAPN11. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction.|
|Cellular Location||Cytoplasmic vesicle, secretory vesicle, acrosome|
|Tissue Location||Highest expression in testis.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Calpains constitute a family of intracellularcalcium-dependent cysteine proteases. There are eight members inthis superfamily. They consist of a variable 80 kDa subunit and aninvariant 30 kDa subunit. This calpain protein appears to haveprotease activity and calcium-binding ability. A similar mouseprotein may play a functional role in spermatogenesis and in theregulation of calcium-dependent signal transduction events duringmeiosis.
Ben-Aharon, I., et al. Mol. Reprod. Dev. 73(6):767-773(2006)Dear, T.N., et al. Genomics 59(2):243-247(1999)Rojas, F.J., et al. Mol. Hum. Reprod. 5(6):520-526(1999)Saido, T.C., et al. FASEB J. 8(11):814-822(1994)Melloni, E., et al. Trends Neurosci. 12(11):438-444(1989)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.